NeuroOne Announces Expansion Of Existing Distribution Agreement With Zimmer Biomet For Commercialization Of OneRF Ablation System; NeuroOne Will Receive An Upfront Payment Of $3M; License Provides Exclusive Commercialization Rights For U.S....
NeuroOne Announces Expansion Of Existing Distribution Agreement With Zimmer Biomet For Commercialization Of OneRF Ablation System; NeuroOne Will Receive An Upfront Payment Of $3M; License Provides Exclusive Commercialization Rights For U.S....
NeuroOne Announces Expansion Of Existing Distribution Agreement With Zimmer Biomet For Commercialization Of OneRF Ablation System; NeuroOne Will Receive An Upfront Payment Of $3M; License Provides Exclusive Commercialization Rights For U.S. Distribution And Certain OUS Markets
NeuroOne宣佈擴大與Zimmer Biomet的現有分銷協議，用於商業化OneRF消融系統；NeuroOne將收到300萬美元的預付款；許可提供美國分銷和部分海外市場的獨家商業化權利
License Provides Exclusive Commercialization Rights for US Distribution and Certain OUS Markets
Agreement expected to boost NeuroOne sales revenue and profitability
許可證爲美國分銷和部分海外市場提供獨家商業化權利
協議預計將提升NeuroOne的銷售收入和盈利能力
EDEN PRAIRIE, Minn., Oct. 31, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced the execution of an amendment to its existing distribution agreement with Zimmer Biomet that will provide Zimmer Biomet with certain exclusive rights to distribute NeuroOne's OneRF Ablation System for use in the brain.
明尼蘇達州伊甸市，2024年10月31日（全球新聞通訊社） - NeuroOne醫療技術公司（NASDAQ:NMTC）（"NeuroOne"或"公司"），一家專注於改善神經疾病患者手術護理選擇和結果的醫療科技公司，今天宣佈與Zimmer Biomet修改其現有分銷協議的執行，該協議將向Zimmer Biomet提供特定獨家權利，用於分銷NeuroOne的OneRF消融系統供腦部使用
譯文內容由第三人軟體翻譯。
